StonvexLoading…
StonvexStonvexStonvexCore line items from CYRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $176.18M | $156.77M | $168.66M | $237.28M |
Operating Income | $-36.81M | $-121.67M | $-100.54M | $-31.90M |
Net Income | $78.30M | $-114.76M | $-99.59M | $-37.33M |
EPS (Diluted) | $1.40 | $-2.49 | $-2.21 | $-0.93 |
Total Assets | $764.99M | $703.49M | $957.74M | $1.04B |
Total Liabilities | $262.35M | $301.59M | $468.72M | $482.91M |
Cash & Equivalents | $250.49M | $34.14M | $35.19M | $29.23M |
Free Cash Flow OCF − CapEx | $-25.02M | $-33.58M | $-39.54M | $-23.96M |
Shares Outstanding | 49.85M | 49.91M | 48.97M | 48.33M |